Navellier & Associates Inc. Takes $1.04 Million Position in Masimo Co. (NASDAQ:MASI)

Navellier & Associates Inc. bought a new stake in Masimo Co. (NASDAQ:MASI) during the fourth quarter, Holdings Channel reports. The institutional investor bought 6,310 shares of the medical equipment provider’s stock, valued at approximately $1,043,000.

A number of other large investors also recently made changes to their positions in the business. FMR LLC increased its holdings in shares of Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider’s stock valued at $900,860,000 after purchasing an additional 1,970,883 shares during the period. State Street Corp increased its holdings in shares of Masimo by 0.7% in the 3rd quarter. State Street Corp now owns 1,438,814 shares of the medical equipment provider’s stock valued at $191,837,000 after purchasing an additional 10,179 shares during the period. Westfield Capital Management Co. LP increased its holdings in shares of Masimo by 23.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after purchasing an additional 262,370 shares during the period. Geode Capital Management LLC increased its holdings in shares of Masimo by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 792,886 shares of the medical equipment provider’s stock valued at $105,741,000 after purchasing an additional 11,984 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Masimo by 9.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 792,166 shares of the medical equipment provider’s stock valued at $105,619,000 after purchasing an additional 70,440 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Performance

Masimo stock opened at $169.96 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The stock has a fifty day moving average price of $172.78 and a two-hundred day moving average price of $152.03. Masimo Co. has a 52-week low of $101.61 and a 52-week high of $184.51. The firm has a market capitalization of $9.10 billion, a P/E ratio of 117.21 and a beta of 1.02.

Analyst Ratings Changes

MASI has been the subject of several recent research reports. Piper Sandler boosted their price target on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Wells Fargo & Company boosted their price target on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Raymond James upped their target price on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research report on Friday, December 27th. Stifel Nicolaus reaffirmed a “buy” rating and set a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Finally, Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Wednesday, January 22nd. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $191.40.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.